Effectiveness and Safety of BIO-11006 Inhalation Solution to Treat the Overproduction of Mucus and Inflammation in COPD (BREATH-1)
This study has been completed.
Sponsor:
BioMarck Pharmaceuticals, Ltd.
Collaborator:
Information provided by:
BioMarck Pharmaceuticals, Ltd.
ClinicalTrials.gov Identifier:
NCT00648245
First received: March 28, 2008
Last updated: February 9, 2011
Last verified: February 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | July 2010 |
| Primary Completion Date: | July 2010 (Final data collection date for primary outcome measure) |